Open AccessAttempts to standardize intradermal drug tests based on molecular mass and on clinical phenotypes. Some pitfalls or exceptions?
Author(s) -
Baló Banga Joseph Mathias,
Vajda Adrienne
Publication year - 2014
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-4-s3-p102
Subject(s) - medicine , erythema multiforme , drug allergy , dermatology , erythema , drug , anaphylaxis , allergy , immunology , pharmacology
Background Despite many efforts to standardize drug skin tests only a few position papers appeared. They were based mainly on prick tests and to lesser extent on intradermal testing. Their standardization is a task set by an ENDA group. Our aim was to re-evaluate our drug skin tests (except patch testing) performed during the past 30 years in a retrospective study and to compare it with a newer protocol applied since 2009.